AGIOS PHARMACEUTICALS, INC.: net_income
| Value | {"amount": -413000000, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2025-01-01 – 2025-12-31 |
| Status | current |
| Entity | AGIOS PHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T14:11:29.585785+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/fc3d43c2-b159-4ca0-b049-39e3d6f61f86
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-26-177086Retrieved: 2026-08-19T14:11:29.585785+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001439222/net-income/2025-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/fc3d43c2-b159-4ca0-b049-39e3d6f61f86
History
- supersedes {"amount": -412781000, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"} (evidence 0001439222-26-000025)